NCT04700709 - Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients. | Biotech Hunter

Enrollment

158

Participants

Timeline

Start Date

January 31, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

January 31, 2025

Conditions

Kidney Transplantation

Interventions

DRUG

Sirolimus Tab.

Orally, once-daily in the morning - The first dose is administered within maximum 6mg/day according to the investigator's judgement, check the blood concentration of Sirolimus at each visit and adjust the dose to acheive the blood concentration maintaining at 3\~8ng/ml.

DRUG

Mycophenolate Mofetil Cap./Tab.

Up to 1g BID(total 2g daily), PO

Trial Locations (1)

Unknown

Severance Hospital, Seoul